Details for 2010728558

Up to date per 02.04.2026

Actions

Title / Product Name

TRANS-4-[[(5S)-5-[[[3,5-BIS(TRIFLUOROMETHYL)PHENYL]METHYL] (2-METHYL-2H-TETRAZOL-5-YL)AMINO]-2,3,4,5-TETRAHYDRO-7,9-DYMETHYL-1H-1-BENZAZEPIN-1-YL]METHYL]-CYCLOHEXANECARBONÄURE

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2010728558

EP Publication Number

2448933

E-Number

629280

Language

PCT Number

US10040125

Publication Date

09.05.2012 A

28.08.2013 B1

Registration Date

28.08.2013

AT Publication Date

15.09.2013

Application Date

28.06.2010

Registration Number

Priorities

30.06.2009

221708 P

IPC

C07D 403/12 20060101AFI20110120BHEP

Maximum Duration of Protection

28.06.2030

Owner

Eli Lilly and CompanyLilly Corporate Center Indianapolis, IN 46285US

Representative

Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT

Inventor

CHEN, XinchaoEli Liily And Company Lilly Corporate Center Indianapolis, Indiana 46285US

FRANK, Scott, AlanEli Lilly And Company Lilly Corporate Center Indianapolis, Indiana 46285US

REMICK, David, MichaelEli Lilly And Company Lilly Corporate Center Indianapolis, Indiana 46285US

PEDERSEN, Steven, WayneEli Lilly And Company Lilly Corporate Center Indianapolis, Indiana 46285US